Cargando…
The relevance of the pharmacologic properties of a progestational agent to its clinical effects as a combination oral contraceptive.
Levonorgestrel (LNg) is known for its marked progestational/contraceptive activity. As shown in animal experiments, however, high doses of LNg are required to elicit an androgenic response; in contrast, considerably lower doses of LNg are required for antiovulatory (contraceptive) action. Thus, a la...
Autores principales: | Upton, G. V., Corbin, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589161/ https://www.ncbi.nlm.nih.gov/pubmed/2534253 |
Ejemplares similares
-
Pharmacology of the Endocrine System and Related Drugs: Progesterone, Progestational Drugs and Antifertility Agents. Volume II
por: Upton, G. Virginia
Publicado: (1974) -
The Link Between Masculinity and Spatial Skills Is Moderated by the Estrogenic and Progestational Activity of Oral Contraceptives
por: Beltz, Adriene M., et al.
Publicado: (2022) -
New Compounds with Progestational Activity: A Review
por: Buckner, Fillmore, et al.
Publicado: (1958) -
The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells
por: Ghatge, Radhika P, et al.
Publicado: (2005) -
SAT-040 Changes in Metabolic Parameters After Administration of Novel Oral Androgens with Progestational Activity for 28 Days
por: Yuen, Fiona, et al.
Publicado: (2020)